MINUTES OF THE DESERT SHIELD BIOLOGICAL WARFARE GROUP

File: 120396_sep96_decls18_0003.txt
Page: 0003
Total Pages: 4

Subject: MINUTES OF THE DESERT SHIELD BIOLOGICAL WARFARE GROUP           

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003203

Folder Title: MINUTES OF THE DESERT SHIELD BIOLOGICAL WARFARE WORKING GROUP-9                                 

Document Number:          1

Folder SEQ  #:        166






                                                UNCLASSIFIED




           SUBJECT: Minutes of Desert Shield BW and MED Issues Work Group


           presumes waiver of informed consent and may have to submit new
           protocol if waiver is not granted by FDA. It is not practical to
           get IC. Discussion on antitoxin as therapy versus prophylaxis.
               b.   Injectable Cholera vaccine has 50% efficacy. Oral
           vaccine is very good, but not licensed. We have a potential
           need, especially if we move out on the offensive.
           ISSUES. Explore options/availability. A task force recommended
           a Swedish traditional vaccine. COL Bancroft will report back.
           One vaccine has a secondary benefit of E. coli (ETEC) control.
           AFMIC was directed to assess BW threat. Best defense is lots of
           IV fluids forward. Mortality is low in well hydrated soldiers.
           Water purification in combat operations is essential. This
           vaccine would be only used with ground forces and may be
           available for Desert Shield.
               C.   Shigella vaccine. COL Bancroft reported that fielding
           vaccine by spring is a long shot. The group recommended to
           pursue development of this vaccine.
               d.   Centoxin. COL Sadoff supports buying a lot and pushing
           to the lowest levels for treating sepsis syndrome and recommends
           it for prophylaxis for chest and abdomen injuries and burns.
           Discussion centered on different views and noted that centoxin
           was not a panacea. However, the original quantity purchased
           should be expanded to meet new troop strengths. There are
           adequate amounts in CONUS on the shelf now. The Centoxin should
           be positioned where surgery is done.
           ISSUES. COL Bancroft will work the options and investigate
           availability/prices. Concerns raised as the drug is still at the
Paleologo presented a Navy perspective on
           the situation. He will be deploying this month and will resolve.



           Group reconvened at 1110 hours.

           5. A DoD Tri-Service Vaccine Committee chaired by COL Tremont
           made recommendations which will be submitted to BG Blanck.
               Cholera/ ETEC
               Oral Typhoid (TY 21A)
               Shigella
               Hepatitis A
               Centoxin

               a.   operational aspects, cost and availability were not
           considered. COL Kussman expressed concern about adding new
           requirements.

               b.   COL Bancroft asked for recommendations-

               (1) Typhoid. Current regimen of paronteral vaccine was
           satisfactory and oral vaccine was not necessary. Look at oral
           vaccine for mid- and long-term use.


                                                UNCLASSIFIED

Document 4 f:/Week-36/BX003203/MINUTES OF THE DESERT SHIELD BIOLOGICAL WARFARE WORKING GROUP-9/minutes of the desert shield biological warfare :11089615085819
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = MINUTES OF THE DESERT SHIELD BIOLOGICAL WARFARE WORKING GROUP-9
Folder Seq # = 166
Subject = MINUTES OF THE DESERT SHIELD BIOLOGICAL WARFARE
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 08-NOV-1996